Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 15   

Articles published

AZN 4,418.50 +3.22 (0.07%)
price chart
Boards wake up to a shareholder spring
Two weeks ago David Brennan, chief executive of AstraZeneca, bowed to pressure from the pharmaceutical group's top shareholders and stepped down at the annual meeting.
Cookson flags breakup as activist fund joins board
(Reuters) - Cookson Group Plc CKSN.L may break up into its two major divisions in an effort to improve shareholder returns and is to admit a partner from ... Investor anger over pay and performance has been a hot-button issue of late, leading to big ...
Pharma tries to avoid falling off 'patent cliff'
Late last month, similar gloomy forecasts at AstraZeneca on sales and earnings weighed heavily in the abrupt resignation of David Brennan as its chief executive amid growing investor pressure for change.
Children's Hospital discovers cause of rare CLOVES disease
Children's Hospital has discovered that a single mutation in a gene is likely to be responsible for a debilitating, rare disease that strikes children, known as CLOVES syndrome.
Superbugs spread to 40 nations threatening India medical tourism
... a microbiologist at Indiana University in Bloomington. She led teams that developed five bacteria-fighting drugs beginning in the 1970s in laboratories that are now part of AstraZeneca Plc, Bristol-Myers Squibb Co., Johnson and Johnson and Pfizer Inc.
Pharmaceuticals
Last month AstraZeneca PLC agreed to acquire Ardea, and Ardea's shares are up about 89% year-to-date. For 2012 Mr. Nadeau's favorite pick is Dynavax Technologies Corp.
Pendragon scraps executive pay plan after revolt
Last week, media doyen Sly Bailey went from Trinity Mirror and the week before AstraZeneca chief executive David Brennan resigned.
Pliazon� cream now available for metastatic colorectal cancer patients
London, 28th May 2012 - Today, Merck Serono announced that they will provide Pliazon�, a cream for the treatment of skin reactions, free to all UK patients undergoing anti-EGFR antibody therapy for metastatic colorectal cancer (mCRC).
Sly Bailey to leave Trinity Mirror
... that shareholder discontent over executive pay has forced out a chief executive before a key vote at a public investor meeting.
Concha shares lifted after confirmation that Hot Tuna business now closed
AstraZeneca on the front foot after US FDA speeds up process for Imfinzi lung cancer drug. Morrisons local. Morrisons upgraded to 'hold' by HSBC after McColl's deal .... Concha PLC RNS announcements. 2017-07-31 Change of Registered Office2017-07-07 ...